Evidence map›Paper›PMID 32708077›Full record

ArticleMarine drugs2020

Epicortical Brevetoxin Treatment Promotes Neural Repair and Functional Recovery after Ischemic Stroke.

Erica Sequeira, Marsha L Pierce, Dina Akasheh, Stacey Sellers, William H Gerwick, Daniel G Baden, Thomas F Murray

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Erica SequeiraDepartment of Pharmacology and Neuroscience, Creighton University, Omaha, NE 68123, USA.
Marsha L PierceDepartment of Pharmacology and Neuroscience, Creighton University, Omaha, NE 68123, USA.
Dina AkashehDepartment of Pharmacology and Neuroscience, Creighton University, Omaha, NE 68123, USA.
Stacey SellersDepartment of Pharmacology and Neuroscience, Creighton University, Omaha, NE 68123, USA.
William H GerwickCenter for Marine Biotechnology & Biomedicine, Scripps Institution of Oceanography, San Diego, La Jolla, CA 92093, USA.ORCID 0000-0003-1403-4458
Daniel G BadenCenter for Marine Science University of North Carolina Wilmington, Wilmington, NC 28409, USA.
Thomas F MurrayDepartment of Pharmacology and Neuroscience, Creighton University, Omaha, NE 68123, USA.ORCID 0000-0001-8521-4507
Creighton University · USScripps Institution of Oceanography · USUniversity of North Carolina Wilmington · US

Funding

Neurotoxins from Marine Algae and CyanobacteriaR01NS053398 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GERWICK, WILLIAM HENRY, MURRAY, THOMAS F · 2005 to 2015
$4.3M
Nebraska EPSCoR National Science Foundation Grant EPS-1004094NINDS NIH HHS NSO53398
6 · The paper itself

Abstract

Emerging literature suggests that after a stroke, the peri-infarct region exhibits dynamic changes in excitability. In rodent stroke models, treatments that enhance excitability in the peri-infarct cerebral cortex promote motor recovery. This increase in cortical excitability and plasticity is opposed by increases in tonic GABAergic inhibition in the peri-infarct zone beginning three days after a stroke in a mouse model. Maintenance of a favorable excitatory-inhibitory balance promoting cerebrocortical excitability could potentially improve recovery. Brevetoxin-2 (PbTx-2) is a voltage-gated sodium channel (VGSC) gating modifier that increases intracellular sodium ([Na

Indexed as

AnimalsBacterial ProteinsCerebral CortexDisease Models, AnimalExcitatory Amino Acid AgonistsInjectionsLuminescent ProteinsMarine ToxinsMice, TransgenicMotor ActivityNeuronal PlasticityOxocinsRecovery of FunctionThrombotic StrokeBacterial ProteinsExcitatory Amino Acid AgonistsLuminescent ProteinsMarine ToxinsOxocinsPtychodiscus brevis T2 toxinyellow fluorescent protein, Bacteriabrevetoxinischemic strokeneuroplasticityperi-infarct

Identifiers

PMID32708077
PMCPMC7404386
OpenAlexW3042246917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.